Daunorubicin + Cytarabine + Venetoclax in de Novo AML

NCT06697327 · clinicaltrials.gov ↗

NA

Phase

ENROLLING_BY_INVITATION

Status

94

Enrollment

OTHER

Sponsor class

Conditions

Leukemia, Myeloid, Acute
Acute Myeloid Leukemia

Interventions

DRUG: (Daunorubicin, Cytarabine, Venetoclax)
DRUG: (Daunorubicin, Cytarabine)

Sponsor

Anhui Medical University

Collaborators

[object Object]